nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—breast cancer	0.123	0.349	CbGaD
Rabeprazole—CYP1A1—breast cancer	0.0961	0.273	CbGaD
Rabeprazole—CYP2D6—breast cancer	0.0715	0.203	CbGaD
Rabeprazole—CYP3A4—breast cancer	0.0613	0.174	CbGaD
Rabeprazole—CYP1A1—Toremifene—breast cancer	0.0395	0.0976	CbGbCtD
Rabeprazole—CYP1A2—Anastrozole—breast cancer	0.0193	0.0477	CbGbCtD
Rabeprazole—CYP1A2—Toremifene—breast cancer	0.0176	0.0436	CbGbCtD
Rabeprazole—CYP2C9—Anastrozole—breast cancer	0.0174	0.043	CbGbCtD
Rabeprazole—ABCG2—Tamoxifen—breast cancer	0.0156	0.0386	CbGbCtD
Rabeprazole—ABCG2—Mitoxantrone—breast cancer	0.0152	0.0377	CbGbCtD
Rabeprazole—CYP1A1—Tamoxifen—breast cancer	0.0144	0.0357	CbGbCtD
Rabeprazole—CYP2C19—Lapatinib—breast cancer	0.0139	0.0345	CbGbCtD
Rabeprazole—CYP3A4—Exemestane—breast cancer	0.0133	0.033	CbGbCtD
Rabeprazole—CYP2C9—Idarubicin—breast cancer	0.0132	0.0326	CbGbCtD
Rabeprazole—ABCG2—Paclitaxel—breast cancer	0.0122	0.0301	CbGbCtD
Rabeprazole—CYP2D6—Idarubicin—breast cancer	0.012	0.0298	CbGbCtD
Rabeprazole—ABCG2—Irinotecan—breast cancer	0.012	0.0297	CbGbCtD
Rabeprazole—ABCG2—Fluorouracil—breast cancer	0.0115	0.0285	CbGbCtD
Rabeprazole—ABCG2—Carboplatin—breast cancer	0.0114	0.0283	CbGbCtD
Rabeprazole—CYP3A4—Letrozole—breast cancer	0.0113	0.028	CbGbCtD
Rabeprazole—CYP3A4—Anastrozole—breast cancer	0.0101	0.025	CbGbCtD
Rabeprazole—CYP3A4—Toremifene—breast cancer	0.00923	0.0228	CbGbCtD
Rabeprazole—ABCG2—Docetaxel—breast cancer	0.00879	0.0217	CbGbCtD
Rabeprazole—CYP3A4—Fulvestrant—breast cancer	0.00859	0.0212	CbGbCtD
Rabeprazole—CYP3A4—Thiotepa—breast cancer	0.00765	0.0189	CbGbCtD
Rabeprazole—CYP2C9—Capecitabine—breast cancer	0.00721	0.0178	CbGbCtD
Rabeprazole—CYP3A4—Ixabepilone—breast cancer	0.007	0.0173	CbGbCtD
Rabeprazole—CYP2C19—Tamoxifen—breast cancer	0.00698	0.0173	CbGbCtD
Rabeprazole—CYP3A4—Lapatinib—breast cancer	0.00674	0.0167	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—breast cancer	0.00655	0.0162	CbGbCtD
Rabeprazole—CYP1A2—Tamoxifen—breast cancer	0.00644	0.0159	CbGbCtD
Rabeprazole—ABCG2—Methotrexate—breast cancer	0.00634	0.0157	CbGbCtD
Rabeprazole—CYP2D6—Vinorelbine—breast cancer	0.00588	0.0145	CbGbCtD
Rabeprazole—CYP2C9—Tamoxifen—breast cancer	0.0058	0.0144	CbGbCtD
Rabeprazole—CYP2D6—Tamoxifen—breast cancer	0.0053	0.0131	CbGbCtD
Rabeprazole—CYP3A4—Raloxifene—breast cancer	0.00511	0.0126	CbGbCtD
Rabeprazole—CYP1A2—Fluorouracil—breast cancer	0.00474	0.0117	CbGbCtD
Rabeprazole—CYP2C9—Paclitaxel—breast cancer	0.00452	0.0112	CbGbCtD
Rabeprazole—CYP2C9—Fluorouracil—breast cancer	0.00428	0.0106	CbGbCtD
Rabeprazole—CYP3A4—Vinorelbine—breast cancer	0.00374	0.00925	CbGbCtD
Rabeprazole—CYP2D6—Vinblastine—breast cancer	0.00362	0.00896	CbGbCtD
Rabeprazole—CYP3A4—Tamoxifen—breast cancer	0.00337	0.00835	CbGbCtD
Rabeprazole—CYP3A4—Mitoxantrone—breast cancer	0.00329	0.00814	CbGbCtD
Rabeprazole—CYP3A4—Paclitaxel—breast cancer	0.00263	0.0065	CbGbCtD
Rabeprazole—CYP3A4—Irinotecan—breast cancer	0.00259	0.00641	CbGbCtD
Rabeprazole—CYP3A4—Vinblastine—breast cancer	0.0023	0.0057	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—breast cancer	0.00223	0.00551	CbGbCtD
Rabeprazole—CYP3A4—Docetaxel—breast cancer	0.0019	0.0047	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—breast cancer	0.00142	0.0035	CbGbCtD
Rabeprazole—ATP4B—endocrine gland—breast cancer	0.000811	0.134	CbGeAlD
Rabeprazole—Pantoprazole—SLCO1B1—breast cancer	0.000688	0.187	CrCbGaD
Rabeprazole—ATP4A—epithelium—breast cancer	0.000561	0.0927	CbGeAlD
Rabeprazole—ATP4A—female reproductive system—breast cancer	0.000417	0.0689	CbGeAlD
Rabeprazole—ATP4A—adrenal gland—breast cancer	0.000407	0.0672	CbGeAlD
Rabeprazole—Omeprazole—CYP1B1—breast cancer	0.000354	0.0962	CrCbGaD
Rabeprazole—ATP4A—endocrine gland—breast cancer	0.000353	0.0583	CbGeAlD
Rabeprazole—Lansoprazole—CYP1B1—breast cancer	0.000324	0.088	CrCbGaD
Rabeprazole—Pantoprazole—ABCG2—breast cancer	0.0003	0.0814	CrCbGaD
Rabeprazole—CYP2C9—mammary gland—breast cancer	0.000273	0.0451	CbGeAlD
Rabeprazole—Omeprazole—ABCG2—breast cancer	0.000244	0.0663	CrCbGaD
Rabeprazole—CYP1A2—nipple—breast cancer	0.000238	0.0393	CbGeAlD
Rabeprazole—CYP1A1—nipple—breast cancer	0.000235	0.0387	CbGeAlD
Rabeprazole—Lansoprazole—ABCG2—breast cancer	0.000223	0.0607	CrCbGaD
Rabeprazole—Esomeprazole—CYP3A4—breast cancer	0.000207	0.0563	CrCbGaD
Rabeprazole—Omeprazole—CYP1A1—breast cancer	0.000191	0.0519	CrCbGaD
Rabeprazole—Lansoprazole—CYP1A1—breast cancer	0.000175	0.0475	CrCbGaD
Rabeprazole—CYP1A1—epithelium—breast cancer	0.000158	0.0261	CbGeAlD
Rabeprazole—CYP1A1—skin of body—breast cancer	0.00015	0.0248	CbGeAlD
Rabeprazole—Pantoprazole—CYP3A4—breast cancer	0.00015	0.0407	CrCbGaD
Rabeprazole—ABCG2—endometrium—breast cancer	0.000149	0.0246	CbGeAlD
Rabeprazole—Omeprazole—CYP2D6—breast cancer	0.000142	0.0387	CrCbGaD
Rabeprazole—ABCG2—uterus—breast cancer	0.000138	0.0227	CbGeAlD
Rabeprazole—ABCG2—pituitary gland—breast cancer	0.000135	0.0223	CbGeAlD
Rabeprazole—ABCG2—adipose tissue—breast cancer	0.000135	0.0222	CbGeAlD
Rabeprazole—CYP1A1—uterus—breast cancer	0.000131	0.0216	CbGeAlD
Rabeprazole—Lansoprazole—CYP2D6—breast cancer	0.00013	0.0354	CrCbGaD
Rabeprazole—CYP1A1—adipose tissue—breast cancer	0.000128	0.0211	CbGeAlD
Rabeprazole—Pantoprazole—ABCB1—breast cancer	0.000125	0.0339	CrCbGaD
Rabeprazole—CYP2C19—endocrine gland—breast cancer	0.000123	0.0204	CbGeAlD
Rabeprazole—Omeprazole—CYP3A4—breast cancer	0.000122	0.0332	CrCbGaD
Rabeprazole—ABCG2—adrenal gland—breast cancer	0.000121	0.0199	CbGeAlD
Rabeprazole—CYP1A1—female reproductive system—breast cancer	0.000117	0.0194	CbGeAlD
Rabeprazole—ABCG2—bone marrow—breast cancer	0.000117	0.0193	CbGeAlD
Rabeprazole—CYP2C9—female reproductive system—breast cancer	0.000113	0.0186	CbGeAlD
Rabeprazole—ABCG2—female gonad—breast cancer	0.000113	0.0186	CbGeAlD
Rabeprazole—Lansoprazole—CYP3A4—breast cancer	0.000112	0.0303	CrCbGaD
Rabeprazole—CYP1A1—female gonad—breast cancer	0.000107	0.0176	CbGeAlD
Rabeprazole—Omeprazole—ABCB1—breast cancer	0.000102	0.0276	CrCbGaD
Rabeprazole—CYP1A2—endocrine gland—breast cancer	0.000101	0.0166	CbGeAlD
Rabeprazole—CYP1A1—endocrine gland—breast cancer	9.93e-05	0.0164	CbGeAlD
Rabeprazole—CYP2C9—endocrine gland—breast cancer	9.56e-05	0.0158	CbGeAlD
Rabeprazole—Lansoprazole—ABCB1—breast cancer	9.3e-05	0.0253	CrCbGaD
Rabeprazole—CYP3A4—female reproductive system—breast cancer	8.61e-05	0.0142	CbGeAlD
Rabeprazole—CYP2D6—female reproductive system—breast cancer	8.48e-05	0.014	CbGeAlD
Rabeprazole—CYP2D6—female gonad—breast cancer	7.71e-05	0.0127	CbGeAlD
Rabeprazole—CYP3A4—endocrine gland—breast cancer	7.29e-05	0.012	CbGeAlD
Rabeprazole—ABCG2—lymph node—breast cancer	7.23e-05	0.0119	CbGeAlD
Rabeprazole—CYP2D6—endocrine gland—breast cancer	7.17e-05	0.0118	CbGeAlD
Rabeprazole—CYP1A1—lymph node—breast cancer	6.87e-05	0.0113	CbGeAlD
Rabeprazole—Bradycardia—Doxorubicin—breast cancer	1.92e-05	0.000113	CcSEcCtD
Rabeprazole—Dyspnoea—Docetaxel—breast cancer	1.92e-05	0.000113	CcSEcCtD
Rabeprazole—Somnolence—Docetaxel—breast cancer	1.91e-05	0.000112	CcSEcCtD
Rabeprazole—Rash—Gemcitabine—breast cancer	1.91e-05	0.000112	CcSEcCtD
Rabeprazole—Dermatitis—Gemcitabine—breast cancer	1.91e-05	0.000112	CcSEcCtD
Rabeprazole—Eye disorder—Epirubicin—breast cancer	1.91e-05	0.000112	CcSEcCtD
Rabeprazole—Tinnitus—Epirubicin—breast cancer	1.9e-05	0.000112	CcSEcCtD
Rabeprazole—Malnutrition—Methotrexate—breast cancer	1.9e-05	0.000112	CcSEcCtD
Rabeprazole—Erythema—Methotrexate—breast cancer	1.9e-05	0.000112	CcSEcCtD
Rabeprazole—Headache—Gemcitabine—breast cancer	1.9e-05	0.000112	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Capecitabine—breast cancer	1.9e-05	0.000112	CcSEcCtD
Rabeprazole—Vomiting—Fluorouracil—breast cancer	1.89e-05	0.000111	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—breast cancer	1.89e-05	0.000111	CcSEcCtD
Rabeprazole—Dyspepsia—Docetaxel—breast cancer	1.89e-05	0.000111	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—breast cancer	1.89e-05	0.000111	CcSEcCtD
Rabeprazole—Insomnia—Capecitabine—breast cancer	1.88e-05	0.000111	CcSEcCtD
Rabeprazole—Rash—Fluorouracil—breast cancer	1.88e-05	0.00011	CcSEcCtD
Rabeprazole—Dermatitis—Fluorouracil—breast cancer	1.88e-05	0.00011	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—breast cancer	1.87e-05	0.00011	CcSEcCtD
Rabeprazole—Paraesthesia—Capecitabine—breast cancer	1.87e-05	0.00011	CcSEcCtD
Rabeprazole—Decreased appetite—Docetaxel—breast cancer	1.87e-05	0.00011	CcSEcCtD
Rabeprazole—Hypersensitivity—Paclitaxel—breast cancer	1.87e-05	0.00011	CcSEcCtD
Rabeprazole—Headache—Fluorouracil—breast cancer	1.87e-05	0.00011	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—breast cancer	1.86e-05	0.00011	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—breast cancer	1.86e-05	0.000109	CcSEcCtD
Rabeprazole—Dysgeusia—Methotrexate—breast cancer	1.86e-05	0.000109	CcSEcCtD
Rabeprazole—Dyspnoea—Capecitabine—breast cancer	1.85e-05	0.000109	CcSEcCtD
Rabeprazole—Angiopathy—Epirubicin—breast cancer	1.85e-05	0.000109	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—breast cancer	1.85e-05	0.000109	CcSEcCtD
Rabeprazole—Nausea—Irinotecan—breast cancer	1.85e-05	0.000109	CcSEcCtD
Rabeprazole—Nausea—Mitoxantrone—breast cancer	1.85e-05	0.000109	CcSEcCtD
Rabeprazole—Pain—Docetaxel—breast cancer	1.84e-05	0.000108	CcSEcCtD
Rabeprazole—Constipation—Docetaxel—breast cancer	1.84e-05	0.000108	CcSEcCtD
Rabeprazole—Back pain—Methotrexate—breast cancer	1.84e-05	0.000108	CcSEcCtD
Rabeprazole—Dyspepsia—Capecitabine—breast cancer	1.83e-05	0.000108	CcSEcCtD
Rabeprazole—Chills—Epirubicin—breast cancer	1.83e-05	0.000108	CcSEcCtD
Rabeprazole—Arrhythmia—Epirubicin—breast cancer	1.82e-05	0.000107	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—breast cancer	1.82e-05	0.000107	CcSEcCtD
Rabeprazole—Asthenia—Paclitaxel—breast cancer	1.82e-05	0.000107	CcSEcCtD
Rabeprazole—Decreased appetite—Capecitabine—breast cancer	1.81e-05	0.000106	CcSEcCtD
Rabeprazole—Alopecia—Epirubicin—breast cancer	1.8e-05	0.000106	CcSEcCtD
Rabeprazole—Nausea—Gemcitabine—breast cancer	1.8e-05	0.000106	CcSEcCtD
Rabeprazole—Pruritus—Paclitaxel—breast cancer	1.79e-05	0.000106	CcSEcCtD
Rabeprazole—Vision blurred—Methotrexate—breast cancer	1.79e-05	0.000105	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—breast cancer	1.78e-05	0.000105	CcSEcCtD
Rabeprazole—Pain—Capecitabine—breast cancer	1.78e-05	0.000105	CcSEcCtD
Rabeprazole—Constipation—Capecitabine—breast cancer	1.78e-05	0.000105	CcSEcCtD
Rabeprazole—Malnutrition—Epirubicin—breast cancer	1.78e-05	0.000104	CcSEcCtD
Rabeprazole—Erythema—Epirubicin—breast cancer	1.78e-05	0.000104	CcSEcCtD
Rabeprazole—Feeling abnormal—Docetaxel—breast cancer	1.77e-05	0.000104	CcSEcCtD
Rabeprazole—Nausea—Fluorouracil—breast cancer	1.77e-05	0.000104	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—breast cancer	1.76e-05	0.000104	CcSEcCtD
Rabeprazole—Ill-defined disorder—Methotrexate—breast cancer	1.76e-05	0.000104	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—breast cancer	1.76e-05	0.000104	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Docetaxel—breast cancer	1.76e-05	0.000103	CcSEcCtD
Rabeprazole—Anaemia—Methotrexate—breast cancer	1.75e-05	0.000103	CcSEcCtD
Rabeprazole—Flatulence—Epirubicin—breast cancer	1.75e-05	0.000103	CcSEcCtD
Rabeprazole—Tension—Epirubicin—breast cancer	1.74e-05	0.000103	CcSEcCtD
Rabeprazole—Dysgeusia—Epirubicin—breast cancer	1.74e-05	0.000102	CcSEcCtD
Rabeprazole—Diarrhoea—Paclitaxel—breast cancer	1.73e-05	0.000102	CcSEcCtD
Rabeprazole—Nervousness—Epirubicin—breast cancer	1.72e-05	0.000101	CcSEcCtD
Rabeprazole—Back pain—Epirubicin—breast cancer	1.72e-05	0.000101	CcSEcCtD
Rabeprazole—Feeling abnormal—Capecitabine—breast cancer	1.71e-05	0.000101	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—breast cancer	1.71e-05	0.000101	CcSEcCtD
Rabeprazole—Malaise—Methotrexate—breast cancer	1.71e-05	0.000101	CcSEcCtD
Rabeprazole—Muscle spasms—Epirubicin—breast cancer	1.71e-05	0.0001	CcSEcCtD
Rabeprazole—Vertigo—Methotrexate—breast cancer	1.7e-05	0.0001	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Capecitabine—breast cancer	1.7e-05	0.0001	CcSEcCtD
Rabeprazole—Body temperature increased—Docetaxel—breast cancer	1.7e-05	9.99e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Docetaxel—breast cancer	1.7e-05	9.99e-05	CcSEcCtD
Rabeprazole—Leukopenia—Methotrexate—breast cancer	1.7e-05	9.99e-05	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—breast cancer	1.69e-05	9.96e-05	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—breast cancer	1.69e-05	9.92e-05	CcSEcCtD
Rabeprazole—Dizziness—Paclitaxel—breast cancer	1.68e-05	9.86e-05	CcSEcCtD
Rabeprazole—Vision blurred—Epirubicin—breast cancer	1.67e-05	9.85e-05	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—breast cancer	1.67e-05	9.81e-05	CcSEcCtD
Rabeprazole—Cough—Methotrexate—breast cancer	1.66e-05	9.74e-05	CcSEcCtD
Rabeprazole—Urticaria—Capecitabine—breast cancer	1.65e-05	9.72e-05	CcSEcCtD
Rabeprazole—Ill-defined disorder—Epirubicin—breast cancer	1.65e-05	9.69e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Capecitabine—breast cancer	1.64e-05	9.68e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Capecitabine—breast cancer	1.64e-05	9.68e-05	CcSEcCtD
Rabeprazole—Convulsion—Methotrexate—breast cancer	1.64e-05	9.67e-05	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—breast cancer	1.64e-05	9.67e-05	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—breast cancer	1.64e-05	9.67e-05	CcSEcCtD
Rabeprazole—Anaemia—Epirubicin—breast cancer	1.64e-05	9.66e-05	CcSEcCtD
Rabeprazole—Agitation—Epirubicin—breast cancer	1.63e-05	9.6e-05	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—breast cancer	1.62e-05	9.53e-05	CcSEcCtD
Rabeprazole—Chest pain—Methotrexate—breast cancer	1.62e-05	9.51e-05	CcSEcCtD
Rabeprazole—Arthralgia—Methotrexate—breast cancer	1.62e-05	9.51e-05	CcSEcCtD
Rabeprazole—Myalgia—Methotrexate—breast cancer	1.62e-05	9.51e-05	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—breast cancer	1.61e-05	9.49e-05	CcSEcCtD
Rabeprazole—Vomiting—Paclitaxel—breast cancer	1.61e-05	9.48e-05	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—breast cancer	1.61e-05	9.47e-05	CcSEcCtD
Rabeprazole—Malaise—Epirubicin—breast cancer	1.6e-05	9.42e-05	CcSEcCtD
Rabeprazole—Rash—Paclitaxel—breast cancer	1.6e-05	9.4e-05	CcSEcCtD
Rabeprazole—Dermatitis—Paclitaxel—breast cancer	1.6e-05	9.4e-05	CcSEcCtD
Rabeprazole—Discomfort—Methotrexate—breast cancer	1.6e-05	9.39e-05	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—breast cancer	1.6e-05	9.39e-05	CcSEcCtD
Rabeprazole—Vertigo—Epirubicin—breast cancer	1.6e-05	9.39e-05	CcSEcCtD
Rabeprazole—Syncope—Epirubicin—breast cancer	1.59e-05	9.37e-05	CcSEcCtD
Rabeprazole—Leukopenia—Epirubicin—breast cancer	1.59e-05	9.35e-05	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—breast cancer	1.59e-05	9.35e-05	CcSEcCtD
Rabeprazole—Headache—Paclitaxel—breast cancer	1.59e-05	9.34e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Docetaxel—breast cancer	1.58e-05	9.31e-05	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—breast cancer	1.58e-05	9.29e-05	CcSEcCtD
Rabeprazole—Palpitations—Epirubicin—breast cancer	1.57e-05	9.23e-05	CcSEcCtD
Rabeprazole—Confusional state—Methotrexate—breast cancer	1.56e-05	9.19e-05	CcSEcCtD
Rabeprazole—Loss of consciousness—Epirubicin—breast cancer	1.56e-05	9.18e-05	CcSEcCtD
Rabeprazole—Cough—Epirubicin—breast cancer	1.55e-05	9.12e-05	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methotrexate—breast cancer	1.55e-05	9.11e-05	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—breast cancer	1.55e-05	9.11e-05	CcSEcCtD
Rabeprazole—Asthenia—Docetaxel—breast cancer	1.54e-05	9.07e-05	CcSEcCtD
Rabeprazole—Convulsion—Epirubicin—breast cancer	1.54e-05	9.05e-05	CcSEcCtD
Rabeprazole—Hypertension—Epirubicin—breast cancer	1.53e-05	9.02e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Capecitabine—breast cancer	1.53e-05	9.02e-05	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—breast cancer	1.52e-05	8.97e-05	CcSEcCtD
Rabeprazole—Pruritus—Docetaxel—breast cancer	1.52e-05	8.94e-05	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—breast cancer	1.52e-05	8.94e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Methotrexate—breast cancer	1.52e-05	8.92e-05	CcSEcCtD
Rabeprazole—Myalgia—Epirubicin—breast cancer	1.51e-05	8.9e-05	CcSEcCtD
Rabeprazole—Arthralgia—Epirubicin—breast cancer	1.51e-05	8.9e-05	CcSEcCtD
Rabeprazole—Chest pain—Epirubicin—breast cancer	1.51e-05	8.9e-05	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—breast cancer	1.51e-05	8.88e-05	CcSEcCtD
Rabeprazole—Anxiety—Epirubicin—breast cancer	1.51e-05	8.86e-05	CcSEcCtD
Rabeprazole—Nausea—Paclitaxel—breast cancer	1.51e-05	8.86e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methotrexate—breast cancer	1.5e-05	8.81e-05	CcSEcCtD
Rabeprazole—Discomfort—Epirubicin—breast cancer	1.49e-05	8.79e-05	CcSEcCtD
Rabeprazole—Asthenia—Capecitabine—breast cancer	1.49e-05	8.78e-05	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—breast cancer	1.48e-05	8.72e-05	CcSEcCtD
Rabeprazole—Dry mouth—Epirubicin—breast cancer	1.48e-05	8.7e-05	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—breast cancer	1.48e-05	8.69e-05	CcSEcCtD
Rabeprazole—Anorexia—Methotrexate—breast cancer	1.48e-05	8.69e-05	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—breast cancer	1.47e-05	8.67e-05	CcSEcCtD
Rabeprazole—Pruritus—Capecitabine—breast cancer	1.47e-05	8.66e-05	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—breast cancer	1.47e-05	8.65e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Docetaxel—breast cancer	1.47e-05	8.65e-05	CcSEcCtD
Rabeprazole—Confusional state—Epirubicin—breast cancer	1.46e-05	8.6e-05	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—breast cancer	1.45e-05	8.54e-05	CcSEcCtD
Rabeprazole—Oedema—Epirubicin—breast cancer	1.45e-05	8.53e-05	CcSEcCtD
Rabeprazole—Anaphylactic shock—Epirubicin—breast cancer	1.45e-05	8.53e-05	CcSEcCtD
Rabeprazole—Hypotension—Methotrexate—breast cancer	1.45e-05	8.51e-05	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—breast cancer	1.44e-05	8.5e-05	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—breast cancer	1.43e-05	8.44e-05	CcSEcCtD
Rabeprazole—Shock—Epirubicin—breast cancer	1.43e-05	8.39e-05	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—breast cancer	1.42e-05	8.38e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Capecitabine—breast cancer	1.42e-05	8.37e-05	CcSEcCtD
Rabeprazole—Dizziness—Docetaxel—breast cancer	1.42e-05	8.36e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Epirubicin—breast cancer	1.42e-05	8.35e-05	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—breast cancer	1.42e-05	8.35e-05	CcSEcCtD
Rabeprazole—Tachycardia—Epirubicin—breast cancer	1.41e-05	8.32e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methotrexate—breast cancer	1.41e-05	8.3e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Epirubicin—breast cancer	1.4e-05	8.24e-05	CcSEcCtD
Rabeprazole—Insomnia—Methotrexate—breast cancer	1.4e-05	8.24e-05	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—breast cancer	1.4e-05	8.23e-05	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—breast cancer	1.4e-05	8.23e-05	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—breast cancer	1.4e-05	8.23e-05	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—breast cancer	1.39e-05	8.2e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Methotrexate—breast cancer	1.39e-05	8.18e-05	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—breast cancer	1.38e-05	8.13e-05	CcSEcCtD
Rabeprazole—Anorexia—Epirubicin—breast cancer	1.38e-05	8.13e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Methotrexate—breast cancer	1.38e-05	8.12e-05	CcSEcCtD
Rabeprazole—Somnolence—Methotrexate—breast cancer	1.38e-05	8.1e-05	CcSEcCtD
Rabeprazole—Dizziness—Capecitabine—breast cancer	1.38e-05	8.09e-05	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—breast cancer	1.37e-05	8.05e-05	CcSEcCtD
Rabeprazole—Vomiting—Docetaxel—breast cancer	1.37e-05	8.04e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Methotrexate—breast cancer	1.36e-05	8.02e-05	CcSEcCtD
Rabeprazole—Rash—Docetaxel—breast cancer	1.35e-05	7.97e-05	CcSEcCtD
Rabeprazole—Hypotension—Epirubicin—breast cancer	1.35e-05	7.97e-05	CcSEcCtD
Rabeprazole—Dermatitis—Docetaxel—breast cancer	1.35e-05	7.96e-05	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—breast cancer	1.35e-05	7.96e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Methotrexate—breast cancer	1.35e-05	7.92e-05	CcSEcCtD
Rabeprazole—Headache—Docetaxel—breast cancer	1.35e-05	7.92e-05	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—breast cancer	1.34e-05	7.89e-05	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—breast cancer	1.34e-05	7.89e-05	CcSEcCtD
Rabeprazole—Pain—Methotrexate—breast cancer	1.32e-05	7.79e-05	CcSEcCtD
Rabeprazole—Vomiting—Capecitabine—breast cancer	1.32e-05	7.78e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Epirubicin—breast cancer	1.32e-05	7.77e-05	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—breast cancer	1.32e-05	7.76e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—breast cancer	1.31e-05	7.73e-05	CcSEcCtD
Rabeprazole—Rash—Capecitabine—breast cancer	1.31e-05	7.72e-05	CcSEcCtD
Rabeprazole—Insomnia—Epirubicin—breast cancer	1.31e-05	7.71e-05	CcSEcCtD
Rabeprazole—Dermatitis—Capecitabine—breast cancer	1.31e-05	7.71e-05	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—breast cancer	1.31e-05	7.7e-05	CcSEcCtD
Rabeprazole—Headache—Capecitabine—breast cancer	1.3e-05	7.67e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Epirubicin—breast cancer	1.3e-05	7.66e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—breast cancer	1.3e-05	7.63e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Epirubicin—breast cancer	1.29e-05	7.6e-05	CcSEcCtD
Rabeprazole—Somnolence—Epirubicin—breast cancer	1.29e-05	7.58e-05	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—breast cancer	1.28e-05	7.52e-05	CcSEcCtD
Rabeprazole—Nausea—Docetaxel—breast cancer	1.28e-05	7.51e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Methotrexate—breast cancer	1.28e-05	7.51e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Epirubicin—breast cancer	1.28e-05	7.51e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methotrexate—breast cancer	1.27e-05	7.45e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Epirubicin—breast cancer	1.26e-05	7.41e-05	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—breast cancer	1.25e-05	7.37e-05	CcSEcCtD
Rabeprazole—Constipation—Epirubicin—breast cancer	1.24e-05	7.29e-05	CcSEcCtD
Rabeprazole—Pain—Epirubicin—breast cancer	1.24e-05	7.29e-05	CcSEcCtD
Rabeprazole—Nausea—Capecitabine—breast cancer	1.24e-05	7.27e-05	CcSEcCtD
Rabeprazole—Urticaria—Methotrexate—breast cancer	1.23e-05	7.24e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Methotrexate—breast cancer	1.22e-05	7.2e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Methotrexate—breast cancer	1.22e-05	7.2e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.22e-05	7.19e-05	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—breast cancer	1.21e-05	7.14e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—breast cancer	1.2e-05	7.08e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—breast cancer	1.2e-05	7.03e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Epirubicin—breast cancer	1.19e-05	7.03e-05	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—breast cancer	1.19e-05	7.01e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Epirubicin—breast cancer	1.19e-05	6.97e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—breast cancer	1.18e-05	6.95e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—breast cancer	1.17e-05	6.86e-05	CcSEcCtD
Rabeprazole—Urticaria—Epirubicin—breast cancer	1.15e-05	6.77e-05	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—breast cancer	1.15e-05	6.75e-05	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—breast cancer	1.15e-05	6.75e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Epirubicin—breast cancer	1.15e-05	6.74e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Epirubicin—breast cancer	1.15e-05	6.74e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Methotrexate—breast cancer	1.14e-05	6.71e-05	CcSEcCtD
Rabeprazole—Asthenia—Methotrexate—breast cancer	1.11e-05	6.54e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—breast cancer	1.11e-05	6.5e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—breast cancer	1.1e-05	6.45e-05	CcSEcCtD
Rabeprazole—Pruritus—Methotrexate—breast cancer	1.1e-05	6.45e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Epirubicin—breast cancer	1.07e-05	6.28e-05	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—breast cancer	1.07e-05	6.27e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—breast cancer	1.06e-05	6.24e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—breast cancer	1.06e-05	6.24e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Methotrexate—breast cancer	1.06e-05	6.23e-05	CcSEcCtD
Rabeprazole—Asthenia—Epirubicin—breast cancer	1.04e-05	6.12e-05	CcSEcCtD
Rabeprazole—Pruritus—Epirubicin—breast cancer	1.03e-05	6.03e-05	CcSEcCtD
Rabeprazole—Dizziness—Methotrexate—breast cancer	1.02e-05	6.03e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Epirubicin—breast cancer	9.92e-06	5.83e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—breast cancer	9.88e-06	5.81e-05	CcSEcCtD
Rabeprazole—Vomiting—Methotrexate—breast cancer	9.85e-06	5.79e-05	CcSEcCtD
Rabeprazole—Rash—Methotrexate—breast cancer	9.76e-06	5.75e-05	CcSEcCtD
Rabeprazole—Dermatitis—Methotrexate—breast cancer	9.76e-06	5.74e-05	CcSEcCtD
Rabeprazole—Headache—Methotrexate—breast cancer	9.7e-06	5.71e-05	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—breast cancer	9.62e-06	5.66e-05	CcSEcCtD
Rabeprazole—Dizziness—Epirubicin—breast cancer	9.58e-06	5.64e-05	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—breast cancer	9.49e-06	5.58e-05	CcSEcCtD
Rabeprazole—Vomiting—Epirubicin—breast cancer	9.22e-06	5.42e-05	CcSEcCtD
Rabeprazole—Nausea—Methotrexate—breast cancer	9.2e-06	5.41e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—breast cancer	9.18e-06	5.4e-05	CcSEcCtD
Rabeprazole—Rash—Epirubicin—breast cancer	9.14e-06	5.38e-05	CcSEcCtD
Rabeprazole—Dermatitis—Epirubicin—breast cancer	9.13e-06	5.37e-05	CcSEcCtD
Rabeprazole—Headache—Epirubicin—breast cancer	9.08e-06	5.34e-05	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—breast cancer	8.87e-06	5.22e-05	CcSEcCtD
Rabeprazole—Nausea—Epirubicin—breast cancer	8.61e-06	5.07e-05	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—breast cancer	8.53e-06	5.02e-05	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—breast cancer	8.46e-06	4.97e-05	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—breast cancer	8.45e-06	4.97e-05	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—breast cancer	8.4e-06	4.94e-05	CcSEcCtD
Rabeprazole—Nausea—Doxorubicin—breast cancer	7.97e-06	4.69e-05	CcSEcCtD
Rabeprazole—CYP1A1—Metabolism—HMOX1—breast cancer	3.44e-06	5.33e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA4—breast cancer	3.43e-06	5.32e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA9—breast cancer	3.43e-06	5.32e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ITPR1—breast cancer	3.43e-06	5.32e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC2A1—breast cancer	3.42e-06	5.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NQO1—breast cancer	3.42e-06	5.3e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOA2—breast cancer	3.41e-06	5.29e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.4e-06	5.28e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOA2—breast cancer	3.38e-06	5.25e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTR—breast cancer	3.37e-06	5.23e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CPT1A—breast cancer	3.37e-06	5.23e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCG2—breast cancer	3.37e-06	5.23e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.35e-06	5.19e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA2—breast cancer	3.35e-06	5.19e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPX2—breast cancer	3.35e-06	5.19e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP3A4—breast cancer	3.33e-06	5.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.32e-06	5.14e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—FASN—breast cancer	3.31e-06	5.13e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HPGDS—breast cancer	3.31e-06	5.13e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPX4—breast cancer	3.3e-06	5.12e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SULT1A1—breast cancer	3.3e-06	5.12e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCB1—breast cancer	3.3e-06	5.12e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BCHE—breast cancer	3.3e-06	5.11e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HBA1—breast cancer	3.28e-06	5.09e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—FASN—breast cancer	3.28e-06	5.09e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1B1—breast cancer	3.28e-06	5.08e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BCHE—breast cancer	3.27e-06	5.07e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC5A5—breast cancer	3.26e-06	5.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TYMS—breast cancer	3.24e-06	5.02e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC5A5—breast cancer	3.23e-06	5.01e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA1—breast cancer	3.23e-06	5e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—IDH1—breast cancer	3.23e-06	5e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.22e-06	4.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—breast cancer	3.21e-06	4.97e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ACHE—breast cancer	3.21e-06	4.97e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PLA2G4A—breast cancer	3.2e-06	4.97e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—breast cancer	3.2e-06	4.97e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NCOR1—breast cancer	3.2e-06	4.97e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NAT2—breast cancer	3.19e-06	4.95e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NQO1—breast cancer	3.15e-06	4.88e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC2A1—breast cancer	3.15e-06	4.88e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NCOA1—breast cancer	3.13e-06	4.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC2A1—breast cancer	3.12e-06	4.83e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NQO1—breast cancer	3.12e-06	4.83e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CD—breast cancer	3.09e-06	4.79e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—STK11—breast cancer	3.08e-06	4.78e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP19A1—breast cancer	3.08e-06	4.78e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP3A4—breast cancer	3.07e-06	4.76e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GPX1—breast cancer	3.07e-06	4.76e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.05e-06	4.73e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—breast cancer	3.05e-06	4.73e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP3A4—breast cancer	3.04e-06	4.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP17A1—breast cancer	3.03e-06	4.71e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.03e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1B1—breast cancer	3.02e-06	4.68e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ERCC2—breast cancer	3.01e-06	4.67e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ENO1—breast cancer	3e-06	4.66e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS1—breast cancer	3e-06	4.66e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.99e-06	4.64e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1B1—breast cancer	2.99e-06	4.64e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.96e-06	4.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.95e-06	4.58e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2D6—breast cancer	2.95e-06	4.57e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.93e-06	4.55e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NOS3—breast cancer	2.92e-06	4.52e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.89e-06	4.49e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOA2—breast cancer	2.89e-06	4.48e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOA1—breast cancer	2.88e-06	4.46e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—COMT—breast cancer	2.87e-06	4.44e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTP1—breast cancer	2.85e-06	4.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOA1—breast cancer	2.85e-06	4.42e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—STK11—breast cancer	2.84e-06	4.4e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP19A1—breast cancer	2.84e-06	4.4e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MTHFR—breast cancer	2.83e-06	4.39e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMOX1—breast cancer	2.81e-06	4.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP19A1—breast cancer	2.81e-06	4.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—STK11—breast cancer	2.81e-06	4.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ITPR1—breast cancer	2.81e-06	4.35e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—FASN—breast cancer	2.8e-06	4.35e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MED12—breast cancer	2.8e-06	4.34e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—DPYD—breast cancer	2.8e-06	4.34e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BCHE—breast cancer	2.79e-06	4.33e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC5A5—breast cancer	2.76e-06	4.28e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDOA—breast cancer	2.75e-06	4.27e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCB1—breast cancer	2.7e-06	4.19e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CB—breast cancer	2.69e-06	4.17e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOA3—breast cancer	2.67e-06	4.15e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—breast cancer	2.67e-06	4.14e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC2A1—breast cancer	2.66e-06	4.13e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NQO1—breast cancer	2.66e-06	4.13e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC2A2—breast cancer	2.66e-06	4.12e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TYMS—breast cancer	2.65e-06	4.11e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.64e-06	4.09e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—COMT—breast cancer	2.64e-06	4.09e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTP1—breast cancer	2.62e-06	4.07e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NCOR1—breast cancer	2.62e-06	4.06e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—breast cancer	2.62e-06	4.06e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.62e-06	4.06e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—COMT—breast cancer	2.61e-06	4.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAV1—breast cancer	2.61e-06	4.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.61e-06	4.05e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTR—breast cancer	2.6e-06	4.03e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCG2—breast cancer	2.6e-06	4.03e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CPT1A—breast cancer	2.6e-06	4.03e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTP1—breast cancer	2.6e-06	4.03e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP3A4—breast cancer	2.6e-06	4.03e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMOX1—breast cancer	2.59e-06	4.01e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.59e-06	4.01e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ITPR1—breast cancer	2.58e-06	4e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMOX1—breast cancer	2.56e-06	3.98e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ITPR1—breast cancer	2.56e-06	3.97e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1B1—breast cancer	2.55e-06	3.96e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HPGDS—breast cancer	2.55e-06	3.96e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HBA1—breast cancer	2.54e-06	3.93e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GPX1—breast cancer	2.51e-06	3.89e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.51e-06	3.88e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.49e-06	3.87e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1A1—breast cancer	2.48e-06	3.85e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCB1—breast cancer	2.48e-06	3.85e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ACHE—breast cancer	2.47e-06	3.84e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—breast cancer	2.47e-06	3.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ERCC2—breast cancer	2.46e-06	3.82e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCB1—breast cancer	2.46e-06	3.82e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TYMS—breast cancer	2.44e-06	3.78e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOA1—breast cancer	2.44e-06	3.78e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TYMS—breast cancer	2.42e-06	3.75e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOR1—breast cancer	2.41e-06	3.74e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.41e-06	3.74e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—breast cancer	2.41e-06	3.74e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—STK11—breast cancer	2.4e-06	3.72e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP19A1—breast cancer	2.4e-06	3.72e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.39e-06	3.71e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOR1—breast cancer	2.39e-06	3.71e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—breast cancer	2.39e-06	3.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—breast cancer	2.38e-06	3.69e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP17A1—breast cancer	2.34e-06	3.63e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—breast cancer	2.33e-06	3.61e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ENO1—breast cancer	2.32e-06	3.6e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS1—breast cancer	2.32e-06	3.6e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTHFR—breast cancer	2.32e-06	3.59e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GPX1—breast cancer	2.31e-06	3.58e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GPX1—breast cancer	2.29e-06	3.55e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1A1—breast cancer	2.29e-06	3.54e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2D6—breast cancer	2.27e-06	3.53e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ERCC2—breast cancer	2.27e-06	3.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1A1—breast cancer	2.27e-06	3.51e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.25e-06	3.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ERCC2—breast cancer	2.25e-06	3.48e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—COMT—breast cancer	2.23e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOA2—breast cancer	2.23e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTP1—breast cancer	2.22e-06	3.45e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMOX1—breast cancer	2.19e-06	3.4e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ITPR1—breast cancer	2.19e-06	3.39e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—FASN—breast cancer	2.16e-06	3.36e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BCHE—breast cancer	2.16e-06	3.34e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAV1—breast cancer	2.14e-06	3.31e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTHFR—breast cancer	2.13e-06	3.3e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC5A5—breast cancer	2.13e-06	3.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTHFR—breast cancer	2.11e-06	3.27e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCB1—breast cancer	2.1e-06	3.26e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CD—breast cancer	2.09e-06	3.24e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TYMS—breast cancer	2.07e-06	3.2e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—breast cancer	2.06e-06	3.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NQO1—breast cancer	2.06e-06	3.19e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC2A1—breast cancer	2.06e-06	3.19e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—breast cancer	2.04e-06	3.17e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.04e-06	3.17e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOR1—breast cancer	2.04e-06	3.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.04e-06	3.17e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NOS3—breast cancer	1.97e-06	3.06e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1B1—breast cancer	1.97e-06	3.06e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAV1—breast cancer	1.97e-06	3.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GPX1—breast cancer	1.96e-06	3.03e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAV1—breast cancer	1.95e-06	3.02e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—breast cancer	1.95e-06	3.02e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1A1—breast cancer	1.94e-06	3e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.93e-06	3e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ERCC2—breast cancer	1.92e-06	2.98e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOA1—breast cancer	1.88e-06	2.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.86e-06	2.89e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—STK11—breast cancer	1.85e-06	2.87e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP19A1—breast cancer	1.85e-06	2.87e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CB—breast cancer	1.82e-06	2.83e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—breast cancer	1.81e-06	2.8e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTHFR—breast cancer	1.8e-06	2.8e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—breast cancer	1.79e-06	2.78e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—breast cancer	1.77e-06	2.75e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—COMT—breast cancer	1.72e-06	2.67e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTP1—breast cancer	1.72e-06	2.66e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CD—breast cancer	1.71e-06	2.65e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMOX1—breast cancer	1.69e-06	2.62e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—breast cancer	1.69e-06	2.62e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ITPR1—breast cancer	1.69e-06	2.62e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAV1—breast cancer	1.66e-06	2.58e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—breast cancer	1.64e-06	2.54e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCB1—breast cancer	1.62e-06	2.52e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NOS3—breast cancer	1.62e-06	2.5e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TYMS—breast cancer	1.59e-06	2.47e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.59e-06	2.47e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—breast cancer	1.58e-06	2.44e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOR1—breast cancer	1.58e-06	2.44e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.58e-06	2.44e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—breast cancer	1.57e-06	2.44e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CD—breast cancer	1.57e-06	2.44e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CD—breast cancer	1.56e-06	2.42e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—breast cancer	1.55e-06	2.41e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—breast cancer	1.54e-06	2.39e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—breast cancer	1.52e-06	2.35e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPX1—breast cancer	1.51e-06	2.34e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1A1—breast cancer	1.49e-06	2.32e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CB—breast cancer	1.49e-06	2.31e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NOS3—breast cancer	1.49e-06	2.3e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ERCC2—breast cancer	1.48e-06	2.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—breast cancer	1.48e-06	2.29e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NOS3—breast cancer	1.47e-06	2.28e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTHFR—breast cancer	1.39e-06	2.16e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CB—breast cancer	1.37e-06	2.13e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CB—breast cancer	1.36e-06	2.11e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—breast cancer	1.36e-06	2.11e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—breast cancer	1.35e-06	2.09e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—breast cancer	1.34e-06	2.08e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CD—breast cancer	1.33e-06	2.07e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—breast cancer	1.32e-06	2.04e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—breast cancer	1.29e-06	2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAV1—breast cancer	1.28e-06	1.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NOS3—breast cancer	1.26e-06	1.95e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—breast cancer	1.19e-06	1.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—breast cancer	1.17e-06	1.82e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—breast cancer	1.17e-06	1.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CB—breast cancer	1.16e-06	1.8e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—breast cancer	1.15e-06	1.79e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—breast cancer	1.11e-06	1.72e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CD—breast cancer	1.03e-06	1.6e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—breast cancer	1.02e-06	1.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—breast cancer	1e-06	1.56e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NOS3—breast cancer	9.71e-07	1.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—breast cancer	9.09e-07	1.41e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—breast cancer	9.07e-07	1.41e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CB—breast cancer	8.97e-07	1.39e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—breast cancer	8.89e-07	1.38e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—breast cancer	8.36e-07	1.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—breast cancer	8.29e-07	1.29e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—breast cancer	7.75e-07	1.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—breast cancer	7.43e-07	1.15e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—breast cancer	7.08e-07	1.1e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—breast cancer	6.83e-07	1.06e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—breast cancer	6.77e-07	1.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—breast cancer	5.79e-07	8.97e-06	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—breast cancer	5.47e-07	8.48e-06	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—breast cancer	4.47e-07	6.92e-06	CbGpPWpGaD
